IndraLab

Statements


[ 1 , 2 , 4 ]-triazolo- [ 1 inhibits KCNH2. 1 / 1
| 1

reach
"[1, 2, 4]-triazolo- [1, 4]-oxazepine were found to decrease hERG activity and 2-fold decrease in GPR142 potency."